KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Non-Current Assets (2016 - 2025)

Cvs Health (CVS) has disclosed Non-Current Assets for 17 consecutive years, with $178.8 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Assets fell 3.11% year-over-year to $178.8 billion, compared with a TTM value of $722.1 billion through Dec 2025, down 1.68%, and an annual FY2025 reading of $178.8 billion, down 3.11% over the prior year.
  • Non-Current Assets was $178.8 billion for Q4 2025 at Cvs Health, roughly flat from $178.2 billion in the prior quarter.
  • Across five years, Non-Current Assets topped out at $185.1 billion in Q3 2024 and bottomed at -$68.3 billion in Q3 2022.
  • Average Non-Current Assets over 5 years is $165.1 billion, with a median of $178.5 billion recorded in 2025.
  • The sharpest move saw Non-Current Assets tumbled 139.27% in 2022, then soared 365.09% in 2023.
  • Year by year, Non-Current Assets stood at $173.0 billion in 2021, then dropped by 5.98% to $162.6 billion in 2022, then increased by 11.82% to $181.9 billion in 2023, then grew by 1.48% to $184.6 billion in 2024, then decreased by 3.11% to $178.8 billion in 2025.
  • Business Quant data shows Non-Current Assets for CVS at $178.8 billion in Q4 2025, $178.2 billion in Q3 2025, and $182.7 billion in Q2 2025.